Jason Coogan, Simplex Trading, joins 'Squawk on the Street' to discuss the relationship between oil and stocks, how traders ...

Herpes zoster ophthalmicus is associated with an increased risk for subsequent malignancy among individuals with an ...

Stand with science,” the World Health Organization (WHO), the United Nations’ specialised agency for public health, ...

LILONGWE-(MaraviPost)-Newly promoted FDH Premiership side Masters Football Club continued their preseason preparations in ...

The retraction came from Neurobiology of Aging, which removed a 2011 paper claiming to show that a version of a protein ...

Replimune received a second FDA complete response letter for RP1 in advanced melanoma, raising questions about the viability of its oncolytic immunotherapy program. Replimune Group received a complete ...

In this conference report from ABRF 2026, the authors reflect on the meeting's insights into core facility research and ...

Replimune has had its advanced melanoma treatment RP1 turned down by the FDA for a second time, a decision that has led the company to accuse the agency of inconsistencies in its review of the drug.

Trump says he doesn't know if he backs constitutional due process rights in new interview President Donald Trump is circumspect about his duties to uphold due process rights laid out in the ...

Replimune disagrees with the FDA about whether the data set, upon which breakthrough therapy designation was awarded, is sufficient to allow this promising medicine to be made available to advanced ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...